Information about Nb Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0465.917.724

VAT liability
Yes
Established
09-04-1999
Last balance sheet year
2024
Company size
Small 2,6 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Nb Pharma

2024 2023 2022 2021
Profit/Loss 47,529 28 % 37,081 4410 % 822 555 % -181
Equity 517,232 10 % 469,703 328 % 109,663 1 % 108,841
Gross margin 296,749 16 % 255,554 310239 % -82 69 % -267
Employees 2.6 2.1

Publications from Nb Pharma

Date Publication
10-08-2023 Registered Office - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
11-05-2023 Rubric Restructuring (Fusion, Split, Transfer of Assets, etc...) (NL)
09-12-2022 Resignations - Appointments (NL)
03-05-2021 Resignations - Appointments (NL)
25-11-2020 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Nb Pharma?
The VAT number of Nb Pharma is BE 0465.917.724.
Wat is the PEPPOL ID of Nb Pharma?
The PEPPOL ID of Nb Pharma is 0208:0465917724. Log in or start a free trial to see the full overview.
When was Nb Pharma founded?
Nb Pharma was founded on 09-04-1999.
What is the address of Nb Pharma?
The current registered office of Nb Pharma is located at Albert I laan 255, 8620 Nieuwpoort.
When was the last time Nb Pharma filed their annual financial statements?
The most recent financial statements of Nb Pharma were filed on 17-06-2025.
How many employees does Nb Pharma have?
There are 2,6 FTEs working at Nb Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Nb Pharma?
At the time of its most recent financial statements, Nb Pharma did not publish any turnover figures. Nb Pharma reported a gross margin of €296,748.97.